Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CLGN |
---|---|---|
11:32 ET | 1000 | 3.68 |
11:50 ET | 100 | 3.69 |
12:32 ET | 454 | 3.715 |
02:48 ET | 100 | 3.73 |
03:55 ET | 100 | 3.725 |
04:00 ET | 100 | 3.71 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Collplant Biotechnologies Ltd | 42.8M | -2.4x | --- |
DURECT Corp | 41.6M | -2.6x | --- |
Affimed NV | 49.6M | -0.6x | --- |
Curis Inc | 25.0M | -0.5x | --- |
Syros Pharmaceuticals Inc | 60.7M | -0.6x | --- |
Carisma Therapeutics Inc | 41.5M | -0.6x | --- |
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.8M |
---|---|
Revenue (TTM) | $689.0K |
Shares Outstanding | 11.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-1.53 |
Book Value | $2.47 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 62.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,671.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.